The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs

Current Topics in Medicinal Chemistry

Volumn 10, Issue 5, 2010, Pages 579-595

  Glennon, Richard A ^a   Siripurapu, Uma ^a   Roth, Bryan L ^b   Kolanos, Renata ^a   Bondarev, Mikhail L ^a   Sikazwe, Donald ^a   Lee, Mase ^a   Dukat, Małgorzata ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZENESULFONYL 5 METHOXY N,N DIMETHYLTRYPTAMINE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIDINYL]BENZENESULFONAMIDE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; ARYLSULFONYLTRYPTAMINE; INDOLE; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; HYDROPHOBICITY; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BINDING; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

CHEMISTRY, PHARMACEUTICAL; LIGANDS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPTAMINES;

EID: 77950556899     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610791111542     Document Type: Article

References (59)

1. 6 receptor antagonists for the treatment of CNS disorders. Expert Opin. Ther. Pat, 2002, 12, 513-527.
2. 7. J. Med. Chem., 2003, 6, 2795-2812.
3. 6 receptors. Cum. Drug Targets CNS Neurol Disord., 2004, 3, 59-79.
4. 6 receptor. Drugs Future, 2005, 30, 479-495.
5. 6 receptor ligands as potential cognitive enhancers and antiobesity agents. Drug Dlscov. Today, 2006, 11, 283-299.
6. 6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Pharmacol. Then, 2008, 117, 207-231.
7. 6 receptor. WO 2006126938, 2006.
8. 6 receptor ligands. WO 2006066746, 2006.
9. 6 receptors. J. Med. Chem., 2000, 43, 1011-1018.
10. Glennon, R. A. Strategies for the development of selective serotonergic agents. In: The Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics, Roth, B. L. Ed., Humana Press, NJ 2006. pp. 91-142.
11. 6 receptor ligands. J. Med. Chem., 2005, 48, 1781-1795.
12. 6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats. Br. J. Pharmacol, 2006, 148, 973-983.
13. 6 antagonists. Bioorg. Med. Chem. Lett, 2000, 10, 2295-2299.
14. 6 receptor ligands. J. Med. Chem., 2001, 44, 3881-3895.
15. 6 receptor ligands and their biological functions. Curr. Top. Med. Chem., 2002, 2, 643-654.
16. 1-benzenesulfonyl and related tryptamines. Med. Chem. Res., 2000, 10, 230-242.
17. 6 receptors. Bioorg. Med. Chem. Lett., 2007, 17, 1691-1694.
18. 6 serotonin receptors: receptor modeling studies. J. Med. Chem., 2008, 51, 603-611.
19. 6 receptor ligand templates. Bioorg. Med. Chem. Lett, 2003, 13, 3355-3359.
20. 2A 268-271 °C.
21. 6 serotonin receptors. Bioorg. Med. Chem. Lett, 2005, 15, 5298-5302.
22. Hirst, W. D.; Abrahamsen, B.; Blaney, F. E.; Calver, A. R.; Aloj, L.; Price, G. W.; Medhurst, A. D. Differences in the central nervous system distribution and pharmacology of the mouse 5hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol, 2003, 64, 1296-1308.
23. Siripurapu, U. Structure-affinity studies on tryptamine-derived 5HT6 serotonin receptor ligands. Doctoral, dissertation. Virginia Commonwealth University; Richmond, VA. 2008.
24. 6 serotonin receptor ligands. Med. Chem. Res., 2005, 14, 1-18.
25. 6 serotonin receptors. Bioorg. Med. Chem. Lett, 2006, 16, 3793-3795.
26. 6 serotonin receptor ligands. Bioorg. Med. Chem. Lett., 2004, 14, 1961-1964.
27. 6 serotonin receptors. Bioorg. Med. Chem. Lett, 2006, 16, 5832-5835.
28. 6 serotonin receptors. Bioorg. Med. Chem. Lett, 2005, 15, 1987-1991.
29. 6 receptor ligands. Org. Biomol Chem., 2008, 6, 3795-3810.
30. 6 serotonin receptor agonists. J. Med. Chem., 2009, 52, 675-687.
31. 6 receptor agonist. J. Med. Chem., 2007, 50, 5535-5538.
32. 6 receptor ligands. Bioorg. Med. Chem. Lett., 2004, 14, 5499-5502.
33. 6 serotonin receptor binding of indolealkylamines: A preliminary structure-affinity investigation. Med. Chem. Res., 1999, 9, 108-117.
34. 6 serotonin receptors. J. Med. Chem., 2006, 49, 5217-5225.
35. 6 ligands. Bioorg. Med. Chem. Lett., 2008, 18, 3929-3931.
36. 6 receptor antagonists. Bioorg. Med. Chem. Lett., 2008, 18, 5698-5700.
37. Cole, D. C.; EIlingboe, J. W.; Lennox, W. J.; Mazandarini, H.; Smith, D. L.; Stock, J. R.; Zhang, G.; Zhou, P.; Schechter, L. E. N1Arylsulfonyl-3-(1,2,3, 6-tetrahydropyridin-4-yl)-1H/-indole derivatives are potent and selective 5-HTe receptor antagonists. Bioorg. Med. Chem. Lett., 2005, 15, 379-383. (Pubitemid 39647154)
38. 6 receptor agonists. Bioorg. Med, Chem, Lett., 2005, 15, 4230-4234.
39. 6 receptor antagonists. Bioorg. Med. Chem. Lett., 2005, 15, 4780-4795.
40. 6 affinity. US Pat. 6, 100, 290. August 8, 2000.
41. 6 receptors. Bioorg. Med. Chem. Lett, 2005, 15, 3510-3513.
42. Cole, D. C; Lennox, W. J.; Lobardi, S.; EIlingboe, J. W.; Bernotas, R. C; Tawa, G. J.; Mazandarani, H.; Smith, D. L.; Zhang, G.; Coupet, J.; Schechter, L. E. Discovery of 5-arylsulfonamido-3(pyrrolidin-2-ylmethyl)-l H-indole derivatives as potent, selective 5-HTj receptor agonists and antagonists. J. Med. Chem., 2005, 48, 353-356. (Pubitemid 40139779)
43. 6 serotonin receptor ligands. Bioorg. Med. Chem. Lett., 2005, 15, 1707-1711.
44. 6 receptor antagonists. Bioorg. Med. Chem. Lett., 2005, 15, 4867-4871.
45. 6 receptor ligands. Bioorg. Med. Chem. Lett., 2005, 15, 1393-1396.
46. 6 receptor ligands. Org. Biomol. Chem., 2008, 6, 1802-1807.
47. 6 agonists and antagonists. Bioorg. Med. Chem, 2007, 15, 6208-6226.
48. Liu, K. G.; Lo, J. R.; Comery, T. A.; Zhang, G. M.; Zhang, J. Y.; Kowal, D. M.; Smith, D. L.; Di, L.; Kerns, E. H.; Schechter, L. E.; Robichaud, A. J. 1-Sufonylindazoles as potent and selective 5-HTs ligands. Bioorg. Med. Chem. Lett., 2009, 19, 2413-2415.
49. 6 receptors ligands based on virtual HTS. Bioorg. Med. Chem. Lett., 2007, 17, 6224-6229.
50. 6 receptor antagonists. Bioorg. Med. Chem. Lett., 2007, 17, 3504-3507.
51. 6 antagonists. Bioorg. Med. Chem, Lett., 2009, 19, 2409-2412.
52. Garzya, V.; Forbes, I. Y.; Gribble, A. D.; Hadley, M. S.; Lightfoot, A. P.; Payne, A. H.; Smith, A. B.; Douglas, S. E.; Cooper, D. G.; Stansfield, I. G.; Meeson, M.; Doods, E. E.; Jones, D. N. C.; Wood, M.; Reavill, C; Scorer, C. A.; Worby, A.; Riley, G.; Eddershaw, P.; Ioannou, C; Donati, D.; Hagan, J. J.; Ratti, E. A. Studies toward the identification of a new generation of atypical antipsychotic agents. Bioorg. Med. Chem. Lett, 2007, 17, 400-405.
53. 6 receptor ligands. Bioorg. Med. Chem. Lett., 2009, 19, 1115-1117.
54. 6 receptor antagonists. Bioorg. Med. Chem. Lett., 2008, 18, 738-743.
55. 6 antagonist: One-step synthesis of (E)-3-(benzenesulfonyl)-2(methylsulfanyl)pyrido[1,2-α] pyrimidin-4-ylidenamme from 2(benzenesulfonyl)-3,3-bis(methylsulfanyl) acrylonitrile. J. Med. Chem., 2003, 46, 4834-4837.
56. 6 antagonists. Bioorg. Med. Chem., 2004, 12, 3815-3824.
57. 6 antagonists. Bioorg. Med. Chem., 2004, 12, 3977-3985.
58. 6) receptor antagonists. J. Med. Chem., 2005, 48, 4216-4219.
59. 6 ligands from, common feature pharmacophore hypotheses. J. Chem. Inf. Model, 2008, 48, 107-206.